|

Simvastatin 20mg Clinical Trials

3 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Tongji Hospital1
  • Post Graduate Institute of Medical Education and Research, Chandigarh1
  • National Cancer Institute, Naples1

Indications

  • Cancer2
  • Decompensated Cirrhosis1
  • Cirrhotic Cardiomyopathy1
  • Left Ventricular Diastolic Dysfunction1
  • Liver Disease1

Other3 trials

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
Phase 1/2
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
N/A
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.